Experiment study of PHI on histone methylation and acetylation in Molt-4 cells.
- Author:
Yi-Qun HUANG
1
;
Xu-Dong MA
;
Rui-Ji ZHEN
;
Jen-Wei CHIAO
;
De-Long LIU
Author Information
- Publication Type:Journal Article
- MeSH: Acetylation; drug effects; Apoptosis; drug effects; Cell Cycle; drug effects; Cell Line, Tumor; Cell Proliferation; drug effects; Epigenesis, Genetic; Histone Deacetylases; metabolism; Histones; metabolism; Humans; Isothiocyanates; pharmacology; Methylation; drug effects
- From: Chinese Journal of Hematology 2007;28(9):612-615
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of phenyl-hexyl isothiocyanate (PHI) on acetylation and methylation of histone in acute lymphoblastic leukemia cell line Molt4.
METHODSThe inhibition of cell proliferation was observed by MTT method and clone suppression test. Apoptosis and cell cycle arrest were measured by flow cytometry. The alterations in histone acetyltransferase and acetylation and methylation of histones were detected by Western blot.
RESULTSPHI could up-regulate the expression of acetyltransferase (P300/CBP), markedly induced the accumulation of acetylated histone H3, H4 and methylated histone H3 lysine 4 (H3K4), and inhibited methylation on lysine 9 of H3 (H3K9). The epigenetic regulation resulted in cell cycle arrest at G0/G1 phase, and induction of apoptosis.
CONCLUSIONSPHI can modulate both histone methylation and acetylation. It may serve as a histone deacetylase inhibitor, and might be a potential novel anti-leukemia agent.
